Evidence map›Paper›PMID 32028395›Full record

ArticleMedicine2020

Antimicrobial photodynamic chemotherapy mediated by PapaMBlue on chronic periodontal disease: Study protocol for a randomized, blind, controlled trial.

Giuliana Giovinazzo Anselmo, Ana Carolina Alves Camargo Tortamano, Marcela Letícia Leal Gonçalves, Adriana Leal-Rossi, Bianca Aparecida Godoy-Miranda, Márcia Regina Cabral Oliveira, Pedro Henrique Cabral Oliveira, Carol Brandt Alves, Sandra Kalil Bussadori, Renato Araujo Prates

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Photochemical improvement of antimicrobial photodynamic therapy mediated by methylene blue on periodontal pathogenic bacteria.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Giuliana Giovinazzo AnselmoPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Ana Carolina Alves Camargo TortamanoPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Marcela Letícia Leal GonçalvesPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Adriana Leal-RossiPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Bianca Aparecida Godoy-MirandaPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Márcia Regina Cabral OliveiraPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Pedro Henrique Cabral OliveiraPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Carol Brandt AlvesPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Sandra Kalil BussadoriPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Renato Araujo PratesPost Graduation Program in Biophotonics Applied to Health Sciences Universidade Nove de Julho.
Universidade Nove de Julho · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe elimination of the pathogenic microorganisms of the periodontal pocket is one of the main points for success in periodontal treatment. The objective of this study is to investigate the clinical and antimicrobial effect of papain-mediated photodynamic therapy in the clinical treatment of periodontal disease.

methodsTwenty patients with chronic periodontitis will be selected. Patients will be randomly divided into 2 groups (n = 10). Group 1 will receive conventional periodontal treatment and group 2 will receive conventional treatment and antimicrobial photodynamic therapy (PACT). Conventional treatment will consist of oral hygiene guidance, with brushing technique instructions and recommendation of daily flossing. The calculus deposits on the teeth will be removed with ultrasound equipment and curettes for scraping and root planning. The PACT will be performed at the end of each periodontal treatment session, at sites with bags ≥4 mm. PapaMblue photosensitizer will be deposited in the periodontal pockets with a syringe and a pre-irradiation time of 1 minute will be adopted. Then, the laser emitting wavelength of 660 nm, with power of 100 mW, for 2 minutes, radiant exposure of 30 J/cm and power density of 250 mW/cm will be applied. Patients will undergo clinical evaluations before treatment (day 1) at 30, 60, and 90 days after the end of treatment; and microbiological evaluations before and immediately after treatment. The distribution of the data within each group and the homogeneity of the variances will be verified. With this information, the most appropriate statistical test in each evaluation will be used. The sample calculation is based on the literature and the significance level of 5% will be adopted. DISCUSSION: The combination of PACT with methylene blue in a papain gel and the conventional treatment may increase the reduction of bacteria in periodontal pockets.

Indexed as

Anti-Infective AgentsChronic PeriodontitisMethylene BluePhotosensitizing AgentsAdultCombined Modality TherapyDouble-Blind MethodFemaleHumansMalePhotochemotherapyRandomized Controlled Trials as TopicTreatment OutcomeAnti-Infective AgentsMethylene BluePhotosensitizing Agents

Identifiers

PMID32028395
PMCPMC7015550
OpenAlexW3004916606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.